✦ LIBER ✦

Thiazolothiazepine Inhibitors of HIV-1 Integrase

✍ Scribed by Neamati, Nouri; Turpin, Jim A.; Winslow, Heather E.; Christensen, John L.; Williamson, Karen; Orr, Ann; Rice, William G.; Pommier, Yves; Garofalo, Antonio; Brizzi, Antonella; Campiani, Giuseppe; Fiorini, Isabella; Nacci, Vito

Book ID: 121699773
Publisher: American Chemical Society
Year: 1999
Tongue: English
Weight: 111 KB
Volume: 42
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm990047z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV-1 integrase inhibitor

✍ E. Eich 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Arylamide Inhibitors of HIV-1 Integrase

✍ Zhao, He; Neamati, Nouri; Mazumder, Abhijit; Sunder, Sanjay; Pommier, Yves; Burk 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 373 KB

Coumarin-Based Inhibitors of HIV Integra

Coumarin-Based Inhibitors of HIV Integrase 1

✍ Zhao, He; Neamati, Nouri; Hong, Huixiao; Mazumder, Abhijit; Wang, Shaomeng; Sund 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 514 KB

Hydrazide-Containing Inhibitors of HIV-1

Hydrazide-Containing Inhibitors of HIV-1 Integrase †

✍ Zhao, He; Neamati, Nouri; Sunder, Sanjay; Hong, Huixiao; Wang, Shaomeng; Milne, 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 180 KB

HIV-1 integrase inhibitors: 2003–2004 up

HIV-1 integrase inhibitors: 2003–2004 update

✍ Raveendra Dayam; Jinxia Deng; Nouri Neamati 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

## Abstract The integration of viral cDNA into the host genome is an essential step in the HIV‐1‐life cycle and is mediated by the virally encoded enzyme, integrase (IN). Inhibition of this process provides an attractive strategy for antiviral drug design. The discovery of β‐diketo acid inhibitors

HIV-1 integrase inhibitors: 2005–2006 up

HIV-1 integrase inhibitors: 2005–2006 update

✍ Raveendra Dayam; Rambabu Gundla; Laith Q. Al-Mawsawi; Nouri Neamati 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 813 KB

## Abstract HIV‐1 integrase (IN) catalyzes the integration of proviral DNA into the host genome, an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive strategy for antiretroviral drug design. Currently two IN inhibitors, MK‐0518 and GS‐9137, are in adva